학술논문
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT
Document Type
Article
Author
Geerlinks, A.V.; Scull, B.; Fleischmann, R.; McClain, K.L.; Man, T.-K.; Allen, C.E.; Krupski, C.; Jordan, M.B.; Marsh, R.A.; Pulsipher, M.A.; Eapen, M.; Connelly, J.A.; Bollard, C.M.; Pai, S.-Y.; Duncan, C.N.; Kean, L.S.; Baker, K.S.; Burroughs, L.M.; Andolina, J.R.; Shenoy, S.; Roehrs, P.; Hanna, R.; Talano, J.-A.; Schultz, K.R.; Stenger, E.O.; Lin, H.; Zoref-Lorenz, A.
Source
In: Blood Advances . (Blood Advances, 25 July 2023, 7(14):3725-3734)
Subject
Language
English
ISSN
24739537
24739529
24739529